Uterine carcinosarcoma is a biphasic tumor composed of high-grade carcinoma and sarcoma components. Clinical treatment is generally based on surgery, supplemented by radiotherapy, chemotherapy and other comprehensive treatments. 1. Surgery: Surgery is the first choice for clinical treatment of uterine cancer sarcoma. The purpose of surgery is generally to remove the whole uterus + double adnexa + lymphatic evaluation. 2. Radiotherapy: for patients who cannot be surgically resected, radical radiotherapy can be chosen, including extracorporeal radiotherapy combined with brachytherapy. Postoperative adjuvant radiotherapy can also be chosen according to postoperative pathology. 3. Chemotherapy: postoperative adjuvant chemotherapy or palliative chemotherapy can be chosen according to postoperative staging. Multiple combination programs can be chosen, such as: carboplatin + paclitaxel, isocyclophosphamide + paclitaxel, etc. The specific treatment plan needs to be recommended by the doctor. The specific treatment program needs to be selected under the advice of the doctor.